A Cost and Cost-Threshold Analysis of Implementation of an Evidence-Based Intervention for HIV-Serodiscordant Couples.
AIDS Behav
; 23(9): 2486-2489, 2019 Sep.
Article
en En
| MEDLINE
| ID: mdl-31254191
ABSTRACT
To address gaps in the cost literature by estimating the cost of delivering an evidence-based HIV risk reduction intervention for HIV-serodiscordant, heterosexual, African American couples (Eban II) and calculating the cost-effective thresholds at three participating sites. The cost, cost-saving, and cost-effectiveness thresholds for Eban II were calculated using standard methods. The analytic time period was from July 1 to September 31, 2014. Total costs for 3 months of program implementation were from $13,747 to $25,937, with societal costs ranging from $5632 to $17,008 and program costs ranging from $8115 to $14,122. The costs per participant were from $1621 to $2160; the cost per session (per participant) ranged from $147 to $196. Sites had achievable cost-saving thresholds, which were all less than one for the 3-month costing timeframe.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Negro o Afroamericano
/
Parejas Sexuales
/
Evaluación de Programas y Proyectos de Salud
/
Infecciones por VIH
/
Seronegatividad para VIH
/
Medicina Basada en la Evidencia
/
Conducta de Reducción del Riesgo
Tipo de estudio:
Etiology_studies
/
Evaluation_studies
/
Health_economic_evaluation
Límite:
Adult
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
AIDS Behav
Asunto de la revista:
CIENCIAS DO COMPORTAMENTO
/
SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS)
Año:
2019
Tipo del documento:
Article
País de afiliación:
Estados Unidos